Redefining Market Access – Effective Value Engagement
Phenestra’s latest white paper highlights the challenges in market access and reimbursement for every company involved in developing new and innovative drugs.
Today, every pharmaceutical company has the patient at the heart of its activities, but the patient is not their immediate customer. Two of the main objectives for pharma are access and reimbursement – finding a means to meet patient needs by securing payer endorsement. How can an industry under constant and growing price pressures build support among the network of stakeholders influencing access and reimbursement for an innovative medicine?
This new and exclusive white paper by Phenestra discusses the market access challenges faced by the industry and ways in which to overcome them.
Download this white paper to:
• Understand the key challenges faced by pharmaceutical companies today
• Establish the key decisions in redefining market access
• Align traditional marketing and market access activities
• Identify future payer needs and how these can be met
Click on the ‘Download the white paper’ button now to obtain your free copy.
For more information on Phenestra please visit www.phenestra.com.